Twin Tree Management, LP Vertex Pharmaceuticals Inc Call Options Transaction History

Twin Tree Management, LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $3.45 Million - $3.79 Million	7,500 New	7,500 $3.49 Million
Q1 2024 May 09, 2024	BUY	$407.69 - $446.08 $11.3 Million - $12.4 Million	27,700 New	27,700 $11.6 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $106,206 - $134,070	-600 Reduced 85.71%	100 $22,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $30.4 Million - $40.5 Million	-146,700 Reduced 99.53%	700 $165,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $36.6 Million - $43.4 Million	143,200 Added 3409.52%	147,400 $40.1 Million
Q1 2018 May 09, 2018	SELL	$151.6 - $177.13 $75,800 - $88,565	-500 Reduced 10.64%	4,200 $685,000
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $535,392 - $606,645	3,900 Added 487.5%	4,700 $704,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $118,504 - $129,792	800	800 $122,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.